850 filings
4
NAVB
Navidea Biopharmaceuticals, Inc.
30 Dec 20
NAVIDEA BIOPHARMACEUTICALS / Malcolm G Witter ownership change
4:33pm
3
NAVB
Navidea Biopharmaceuticals, Inc.
30 Dec 20
NAVIDEA BIOPHARMACEUTICALS / Malcolm G Witter ownership change
4:32pm
SC 13D/A
NAVB
Navidea Biopharmaceuticals, Inc.
29 Dec 20
NAVIDEA BIOPHARMACEUTICALS / Scott John K Jr. ownership change
4:15pm
8-K
NAVB
Navidea Biopharmaceuticals, Inc.
28 Dec 20
Navidea Biopharmaceuticals Strengthens Board of Directors with the Appointment of Malcolm Witter
4:19pm
S-8
NAVB
Navidea Biopharmaceuticals, Inc.
13 Nov 20
Registration of securities for employees
4:30pm
8-K
g2imr7ig n77zez
12 Nov 20
Navidea Biopharmaceuticals Reports Third Quarter and Year-to-Date 2020 Financial Results
4:40pm
4
o8u5a0m
6 Nov 20
NAVIDEA BIOPHARMACEUTICALS / Joel H. Kaufman ownership change
5:08pm
3
ozkllgnw h1lag
6 Nov 20
NAVIDEA BIOPHARMACEUTICALS / Joel H. Kaufman ownership change
5:07pm
EFFECT
k6p1szh0 8p
17 Sep 20
Notice of effectiveness
12:15am
CORRESP
dwsf4
14 Sep 20
Correspondence with SEC
12:00am
8-K
camxq2zini9 3vick
10 Sep 20
Submission of Matters to a Vote of Security Holders
4:02pm
4
872egszw uauuh
2 Sep 20
NAVIDEA BIOPHARMACEUTICALS / John K Jr. Scott ownership change
9:47pm
424B5
nx8zji5yo5aiw51npf
2 Sep 20
Prospectus supplement for primary offering
5:31pm
424B5
61purj7fl9gu81uo kmi
2 Sep 20
Prospectus supplement for primary offering
5:30pm
SC 13D/A
56maz
2 Sep 20
NAVIDEA BIOPHARMACEUTICALS / Scott John K Jr. ownership change
5:18pm
8-K
y2s5 3i52jf15giin82
2 Sep 20
Entry into a Material Definitive Agreement
5:04pm
EFFECT
u3ye0jcih
2 Sep 20
Notice of effectiveness
12:15am
UPLOAD
6sc5t
1 Sep 20
Letter from SEC
12:00am
POS AM
vm5 e714unwh0mdxe
28 Aug 20
Prospectus update (post-effective amendment)
8:18am